TH176546B - Composition for improvement or prevention of fatty liver in non-alcoholic people. - Google Patents

Composition for improvement or prevention of fatty liver in non-alcoholic people.

Info

Publication number
TH176546B
TH176546B TH1701004961A TH1701004961A TH176546B TH 176546 B TH176546 B TH 176546B TH 1701004961 A TH1701004961 A TH 1701004961A TH 1701004961 A TH1701004961 A TH 1701004961A TH 176546 B TH176546 B TH 176546B
Authority
TH
Thailand
Prior art keywords
improvement
composition
prevention
fatty liver
alcoholic
Prior art date
Application number
TH1701004961A
Other languages
Thai (th)
Other versions
TH176546A (en
Original Assignee
โคจิน ไลฟ์ ไซเอินซ์ โค แอลทีดี
Filing date
Publication date
Application filed by โคจิน ไลฟ์ ไซเอินซ์ โค แอลทีดี filed Critical โคจิน ไลฟ์ ไซเอินซ์ โค แอลทีดี
Publication of TH176546B publication Critical patent/TH176546B/en
Publication of TH176546A publication Critical patent/TH176546A/en

Links

Claims (1)

1. องค์ประกอบสำหรับการปรับปรุงโรคไขมันพอกตับของคนที่ไม่ได้ดื่มสุรา, ที่ประกอบ รวมด้วยกลูทาไธโอนในรูปส่วนประกอบออกฤทธิ์1. Composition for the improvement of non-alcoholic fatty liver disease, containing glutathione as the active ingredient.
TH1701004961A 2016-03-02 Composition for improvement or prevention of fatty liver in non-alcoholic people. TH176546A (en)

Publications (2)

Publication Number Publication Date
TH176546B true TH176546B (en) 2018-06-07
TH176546A TH176546A (en) 2018-06-07

Family

ID=

Similar Documents

Publication Publication Date Title
WO2015120062A8 (en) Therapeutic compounds and compositions
WO2016142224A8 (en) Fungicidal mixtures comprising strobilurin-type fungicides
EP3539978A4 (en) Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
CA2904166C (en) Formulations with reduced oxidation
WO2017075171A3 (en) Pamam dendrimer based cest imaging agents and uses thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016020408A3 (en) Compounds for preventing ototoxicity
WO2017222819A3 (en) Solid state forms of ixazomib citrate
TH176546B (en) Composition for improvement or prevention of fatty liver in non-alcoholic people.
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
TH176546A (en) Composition for improvement or prevention of fatty liver in non-alcoholic people.
WO2015112168A3 (en) Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
WO2017018686A3 (en) Composition containing manassantin a or manassantin b for non-alcoholic fatty liver disease prevention or treatment
FR3005411B1 (en) ASSOCIATION OF ACTIVE INGREDIENTS FOR ORAL ADMINISTRATION TO ENHANCE THE QUALITY OF NAILS.
ITUA20163937A1 (en) Vehicle for the administration of active ingredients and / or functional ingredients, and compositions containing the same.
TH72745S1 (en) Barrier
DK3595660T3 (en) Compound for use in the prevention and/or treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
TH63018S1 (en) basin
TH169970S (en) basin
UA115290U (en) COMPOSITION IN THE FORM OF SPRAY FOR ORAL APPLICATION CONTAINING CHOLINE ALPHOSCERATE
TH175262B (en) seat
TH173142B (en) Chair for transporting patients
TH63708S1 (en) Toilet bowl
TH164406S (en) Toilet bowl